Purpose of the development: For the rapid assessment of the functional state of the cardiovascular system, in particular screening for coronary heart disease, during mass prophylactic examinations; Additional diagnostic information during stress testing of monitoring the state of the cardiovascular system in dynamics in the treatment of cardiac patients.

Recommended application field: Medical, educational, sports facilities, as well as at home and in the field.

Technical characteristic: - method for recording an electrocardiogram (EX): bipolar from the user's fingers; - EX voltage range: 0.03 to 5 mV; - relative error in measuring EX in the range of 0.5 to 4 mV: ± 7%; - relative error in measuring heart rate (in the range from 30 to 180 beats / min): ± 5%; - testing period - 2 minutes; - sensitivity and specificity exceed 93%; - mean time between failures 2000 hours; - overall dimensions: 100x70x25 mm; - weight: 0.2 kg.

Advantages over analogues: Unlike well-known analogues, FAZAGRAF® allows you to determine subtle changes in the signal, carry additional diagnostic information, and are not taken into account in traditional ECG diagnostics.

The development stage readiness: Introduced in production

Description of the development:
()
The device implements an original technology for processing biosignals in phase space, due to which it is able to identify hidden signs of diseases. The device is simple and easy to use. It is implemented in two versions for examinations in medical institutions and at home.

Information about newness of the development:
there are inventor's certificate -- 1 items
there are Ukrainian patents -- 1 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Combinated reduction to industrial level
Joint production, sale, exploitation

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua